Glencore plc (LON:0IVW)

Intra-Cellular Therapies Revenue

In the year 2024, Glencore had annual revenue of $230.94B USD with 6.02% growth. Glencore had revenue of $113.85B in the half year ending December 31, 2024, a decrease of -6.33%.

• Revenue: $230.94B
• Revenue Growth: +6.02%
• P/S Ratio: 0.19
• Revenue / Employee: $2.74M
• Employees: 84,146
• Market Cap: 35.71B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	230.94B	13.12B	6.02%
Dec 31, 2023	217.83B	-38.16B	-14.91%
Dec 31, 2022	255.98B	52.23B	25.64%
Dec 31, 2021	203.75B	61.41B	43.15%
Dec 31, 2020	142.34B	-72.77B	-33.83%